Regulatory PathRegulatory requirements compared

Active substances

Ethinylestradiol + Norgestimate

Open in the medicines table

SFDA Saudi Arabia — SFDA human drug list

Trade nameStrengthForm · routePackPublic priceTypeCompanyStatus
CILEST TAB0.035, 0.250 mgTablet · Oral use21 BlisterSAR 16.50NCE · PrescriptionJanssen-Cilag International NVWithdrawn by MAH · Not Marketed

US FDA United States — FDA approvals (Drugs@FDA)

ProductStrengthForm · routeApplicantStatusFirst approved
SPRINTEC0.035MG;0.25MGtablet · oral-28BARRPrescription25 Sep 2002
TRI-SPRINTEC0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MGtablet · oral-28BARRPrescription29 Dec 2003
ORTHO TRI-CYCLEN 210.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MGtablet · oral-21ORTHO MCNEIL PHARMPrescription13 May 2005
ORTHO TRI-CYCLEN 280.035MG,0.035MG,0.035MG; 0.18MG,0.215MG,0.25MGtablet · oral-28ORTHO MCNEIL PHARMPrescription13 May 2005
TRI LO SPRINTEC0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MGtablet · oral-28BARR LABS INCPrescription29 Jun 2009
NORGESTIMATE; ETHINYL ESTRADIOL0.215MG; 0.025MG; 0.25MG; 0.025MGtablet · oralWATSON LABSPrescription9 Mar 2011
NORGESTIMATE AND ETHINYL ESTRADIOL0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MGtablet · oral-28GLENMARK PHARMS LTDPrescription17 Jun 2011
NORGESTIMATE; ETHINYL ESTRADIOL0.215MG; 0.035MG; 0.25MG; 0.035MGtablet · oralGLENMARK PHARMS LTDPrescription17 Jun 2011
NORGESTIMATE AND ETHINYL ESTRADIOL0.035MG;0.25MGtablet · oral-28GLENMARK PHARMS LTDPrescription5 Apr 2012
MONO-LINYAH0.035MG;0.25MGtablet · oral-28NOVAST LABS LTDPrescription23 May 2012
TRI-LINYAH0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MGtablet · oral-28NOVAST LABS LTDPrescription30 May 2012
NORGESTIMATE AND ETHINYL ESTRADIOL0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MGtablet · oral-28LUPIN PHARMSPrescription25 Jun 2012
TRI-ESTARYLLA0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MGtablet · oral-28XIROMEDPrescription30 Jan 2013
ESTARYLLA0.035MG;0.25MGtablet · oral-28XIROMEDPrescription30 Jan 2013
NORGESTIMATE AND ETHINYL ESTRADIOL0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MGtablet · oral-28NAARI PTEPrescription7 Apr 2015
NORGESTIMATE AND ETHINYL ESTRADIOL0.035MG;0.25MGtablet · oral-28NAARI PTEPrescription7 Apr 2015
TRI-LO-ESTARYLLA0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MGtablet · oral-28XIROMEDPrescription29 Jun 2015
NORGESTIMATE AND ETHINYL ESTRADIOL0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MGtablet · oral-28GLENMARK SPECLTPrescription23 Feb 2016
NORGESTIMATE AND ETHINYL ESTRADIOL0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MGtablet · oral-28LUPINPrescription26 Apr 2016
NORGESTIMATE AND ETHINYL ESTRADIOL0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MGtablet · oral-28NAARI PTEPrescription12 May 2016
TRI-MILI0.035MG,0.035MG,0.035MG;0.18MG,0.215MG,0.25MGtablet · oral-28AUROBINDO PHARMA LTDPrescription6 Jul 2016
MILI0.035MG;0.25MGtablet · oral-28AUROBINDO PHARMA LTDPrescription7 Jul 2016
NORGESTIMATE AND ETHINYL ESTRADIOL0.035MG;0.25MGtablet · oral-28LUPINPrescription27 Oct 2016
TRI-LO-MILI0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MGtablet · oral-28AUROBINDO PHARMAPrescription4 Nov 2016
TRI-LO-LINYAH0.025MG,0.025MG,0.025MG;0.18MG,0.215MG,0.25MGtablet · oral-28NOVAST LABSPrescription2 Sep 2022

16 more — full table

Canada Canada — marketed products (Health Canada)

BrandDINStrengthForm · routeCompany
TRI-CIRA 21025080870.215 MG; 0.035 MG; 0.25 MG; 0.18 MGTABLET · ORALAPOTEX INC
TRI-CIRA 28025080950.035 MG; 0.18 MG; 0.215 MG; 0.25 MGTABLET · ORALAPOTEX INC
TRI-CIRA LO 21024019670.025 MG; 0.25 MG; 0.215 MG; 0.18 MGTABLET · ORALAPOTEX INC
TRI-CIRA LO 28024019750.025 MG; 0.25 MG; 0.18 MG; 0.215 MGTABLET · ORALAPOTEX INC
TRI-JORDYNA 21024862960.035 MG; 0.18 MG; 0.25 MG; 0.215 MGTABLET · ORALGLENMARK PHARMACEUTICALS CANADA INC.
TRI-JORDYNA 28024863180.035 MG; 0.215 MG; 0.18 MG; 0.25 MGTABLET · ORALGLENMARK PHARMACEUTICALS CANADA INC.

Prices — United States and England

SourceProduct as listedPriceUnit / packDate
US NADACESTARYLLA 0.25-0.035 MG TABLET$0.11481per EA23 Sep 2026
US NADACMILI 0.25-0.035 MG TABLET$0.11481per EA23 Sep 2026
US NADACSPRINTEC 28 DAY TABLET$0.11481per EA23 Sep 2026
US NADACTRI-ESTARYLLA TABLET$0.12642per EA23 Sep 2026
US NADACTRI-LINYAH TABLET$0.12642per EA23 Sep 2026
US NADACTRI-LO-ESTARYLLA TABLET$0.10804per EA23 Sep 2026
US NADACTRI-LO-MILI TABLET$0.10804per EA23 Sep 2026
US NADACTRI-LO-SPRINTEC TABLET$0.10804per EA23 Sep 2026
US NADACTRI-MILI 28 TABLET$0.12642per EA23 Sep 2026
US NADACTRI-SPRINTEC TABLET$0.12642per EA23 Sep 2026
NHS Drug TariffEthinylestradiol 35microgram / Norgestimate 250microgram tablets£4.6563 tablet1 Oct 2026

NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.

Components

Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.